<span item_type="fundamental" item_id="c2acf661e4e064d7ebca67352c2ac688" counter_id="ST/US/SIMAW" env="prod"></span><span item_type="announcement" item_id="516108741360617217" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD 0.07.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not commenced any operations and will not generate operating revenues until after the completion of its Business Combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income (Loss)</strong>: For the three months ended March 31, 2025, net income was $2,222,746, which includes $2,464,218 of interest income earned on the Trust Account, offset by $241,472 of general and administrative costs.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>General and Administrative Expenses</strong>: $241,472 for the three months ended March 31, 2025, compared to $28,464 for the period from January 29, 2024 (inception) to March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow</strong>: Net cash used in operating activities was - $185,388 for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>Cash Balance</strong>: As of March 31, 2025, the cash balance was $511,697.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Interest Income</strong>: Interest earned on cash and marketable securities held in the Trust Account was $2,464,218 for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company intends to effectuate its initial Business Combination using cash from the proceeds of the Initial Public Offering and the Private Placement, among other sources.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>Non-Core Business</strong>: The company may pursue an initial Business Combination in any business or industry, but is focusing on companies in the healthcare industry.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>Priority</strong>: If unable to complete the initial Business Combination by July 11, 2026, the company will cease operations, redeem public shares, and liquidate.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul>

SIM ACQUISITION CORP. I WTS 01/06/31 (TO SUB FOR ORD) | 10-Q: FY2025 Q1 EPS: USD 0.07